Search

everythinglearnresearchcommunity

for

Search:↓

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

A(1-7) treatment reduces symptoms of lupus in mice.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Baricitinib may not always prevent relapse in alopecia areata.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

OR-101 shows promise for treating alopecia areata by improving hair growth.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Targeted cancer therapies often cause serious skin problems that need careful management.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.